Clinical Trial Update: Twice-daily Tacrolimus and Everolimus Convert to Once-daily Tacrolimus and Everolimus in Liver Transplant Recipient [Phase 4]

View source ↗

Summary

Phase 4 trial updating dosing from twice-daily to once-daily tacrolimus and everolimus in liver transplant recipients, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Everolimus (everolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Liver Transplantation | Phase 4 | Status: COMPLETED